Terms: = Testicular cancer AND EPAS1, MOP2, 2034, ENSG00000116016, PASD2, HIF2A, Q99814 AND Treatment
2 results:
1. METTL3 potentiates resistance to cisplatin through m
Wei J; Yin Y; Zhou J; Chen H; Peng J; Yang J; Tang Y
J Cell Mol Med; 2020 Oct; 24(19):11366-11380. PubMed ID: 32857912
[TBL] [Abstract] [Full Text] [Related]
2. testicular cancer.
Peckham M
Acta Oncol; 1988; 27(4):439-53. PubMed ID: 3060153
[TBL] [Abstract] [Full Text] [Related]
